In principle, we can engineer various therapeutic antibodies with the ability to enter the cytosol.

Cell specific targeting

Our antibodies can be modified to specifically target different cell-surface receptors to enhance binding to specific tissues.


Our fully human antibodies do not require chemical conjugation or formulation for delivery. Therefore, the manufacturing procedures we would use are similar to those used for any naked therapeutic antibody.

Mechanism of early endosome escape.

Mechanism of early endosome escape.